(I'm not )
Select a date:
September 20, 2018
September 19, 2018
September 18, 2018
September 17, 2018
September 16, 2018
September 15, 2018
September 14, 2018
September 13, 2018
September 12, 2018
September 11, 2018
September 10, 2018
September 9, 2018
September 8, 2018
September 7, 2018
September 6, 2018
September 5, 2018
September 4, 2018
September 3, 2018
September 2, 2018
September 1, 2018
August 31, 2018
August 30, 2018
August 29, 2018
August 28, 2018
August 27, 2018
August 26, 2018
August 25, 2018
August 24, 2018
August 23, 2018
August 22, 2018
Click here to add topics
Click here to add companies
Industry News, A-Z
No top stories
Financial Services & Investing
Managed Health Care
Commodities & Futures
Cancer & Oncolgy
Huntsman Cancer Foundation Announces Major Gifts to Support Hospital Expansion Plans
Today Huntsman Cancer Foundation (HCF) announced that several individuals and business organizations have committed a total of $40 million to support a proposed major building expansion of Huntsman Cancer Institute (HCI) at the University of Utah...
PR Newswire, 10:38pm ET
New Research Finds Annual Well Visit Increases Likelihood of Preventive Services
A new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit (AWV) between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV....
PR Newswire, 11:23am ET
Scientists Grow Human Esophagus in Lab
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids....
PR Newswire, 11:08am ET
OncoMed Provides Update on Navicixizumab Partnership
OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that Celgene has notified OncoMed that due to strategic product...
GlobeNewswire, 8:08am ET
European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
Array BioPharma Inc. (NASDAQ: ARRY) today announced that the European Commission (EC) has approved BRAFTOVI® in combination with MEKTOVI® for the treatment of adult patients with unresectable or metastatic melanoma with a BRAFV600 mutation, as...
PR Newswire, 2:08pm ET
--- EU approval is based on Phase 3 COLUMBUS trial that demonstrated 14.9 months median progression-free survival and 33.6 months median overall survival versus vemurafenib monotherapy with 7.3 and 16.9 months, respectively - Pierre Fabre...
BusinessWire, 1:28pm ET
Prostate Cancer Diagnosis - Do You Really Know "All" Your Treatment Options?
We live in an era of information overload, frequently confusing and contradictory. The challenge and difficult task of evaluating and understanding available treatment options for prostate cancer is not immune to this quandary....
PR Newswire, 9:28am ET
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-8201 in Combination with KEYTRUDA® (pembrolizumab) in HER2 Expressing Breast and HER2 Expressing or HER2 Mutant Lung Cancers
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., known as MSD outside the United...
PR Newswire, 8:08am ET
GW Cancer Center to concentrate on D.C.-specific health issues Separate language courses are needed for beginning and native speakers Milken to debut podcast exploring common public health issues GSEHD faces long-standing gender imbalance
Researchers and physicians in the GW Cancer Center are targeting health issues that hit close to home. As the center sets its sights on becoming a nationally recognized research hub, officials said researchers and physicians will focus on...
University Wire, 7:23am ET
Global Infusion Pump Market to Witness a CAGR of 6.6% during 2018-2024
The global infusion pump market is expected to grow significantly from USD 9,210 million in 2017 to USD 14,500 million in 2024, at a CAGR of 6.6% from 2018 to 2024. The growth in the market is attributed to the growing incidence of chronic...
GlobeNewswire, 5:38am ET
St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration
-- The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer -- St. Jude and Tessa will pioneer a novel approach to pediatric high grade gliomas, aggressive brain cancers in...
PR Newswire, 7:33pm ET
Australia : How Universities Bring People and Nations Together
I begin by acknowledging the traditional owners of the land on which we meet, the Yugambeh people of south-east Queensland. I pay my respects to your Elders, past and present, who have kept law and language and culture strong in...
Euclid Tenders Info, 6:43pm ET
According to the market research report released by Technavio, the global optical imaging market is expected to accelerate at a CAGR of more than 8% during the forecast period. The increasing market penetration of digital...
BusinessWire, 5:58pm ET
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 1:10 p.m. EDT...
BusinessWire, 4:18pm ET
Digital Landscape: Breast Cancer
Digital Landscape: Breast Cancer Summary"Digital Landscape: Breast Cancer", analyzes digital activities undertaken by pharma in support of therapies for Breast Cancer. Read the full report: https://www.reportlinker.com/p05568478...
PR Newswire, 3:53pm ET
In-Shape Health Clubs To Raise $150,000 For Cancer Research
In-Shape Health Clubs, California's top destination for fitness and recreation, today announced its goal to raise $150,000 for cancer research in the month of October for its 4th annual Fight Cancer campaign....
PR Newswire, 3:33pm ET
UAB receives $11.7 million grant to test weight loss intervention for cancer survivors
Wendy Demark-Wahnefried, Ph.D., R.D.Researchers with the University of Alabama at Birmingham have received a five-year $11.7 million grant from the NIH and National Cancer Institute to test effective and scalable diet and exercise interventions...
University Wire, 3:13pm ET
GenomeDx Achieves Significant Medicare Milestone for Decipher Prostate Biopsy Genomic Classifier
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Noridian GBA, a Medicare Administrative Contractor (MAC), has issued a draft local coverage determination (LCD) for use of the Decipher® Prostate...
PR Newswire, 3:03pm ET
Bone Metastasis Market Outlook 2018 | Development Trends, Market Demands, Industry Analysis & Forecast by 2025
Global Bone Metastasis Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Global Bone Metastasis industry. The report provides a basic overview of the industry including definitions,...
Heraldkeeper, 1:18pm ET
Crocs, Inc. (NASDAQ: CROX), a global leader in innovative casual footwear for women, men and children, today announced that it has partnered with Susan G. Komen(R), the world's leading breast cancer organization, to support...
BusinessWire, 1:18pm ET
1-20 of 187
Next 20 >>
Terms of Service